ANGIODYNAMICS INC — Form 10-K
Filed July 14, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 8/100
What the filing says
AngioDynamics published its Code of Conduct covering all employees, officers, and directors. The document establishes ethics policies on conflicts of interest, healthcare professional interactions, insider trading, accurate disclosures, anti-corruption, antitrust compliance, and workplace conduct. No quantitative business changes, financial impacts, or material transactions are disclosed—this is a governance/compliance document effective March 2026.
Why this rating
Routine governance disclosure; no financial or operational impact. Code of Conduct adoption is standard corporate practice, not business-changing.
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.